BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21527609)

  • 1. Recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: planning sonography for radio frequency ablation.
    Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
    J Ultrasound Med; 2011 May; 30(5):617-24. PubMed ID: 21527609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CO2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Clin Ultrasound; 2007 Feb; 35(2):78-81. PubMed ID: 17195192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil.
    Miyayama S; Matsui O; Yamashiro M; Ryu Y; Kaito K; Ozaki K; Takeda T; Yoneda N; Notsumata K; Toya D; Tanaka N; Mitsui T
    J Vasc Interv Radiol; 2007 Mar; 18(3):365-76. PubMed ID: 17377182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes in echogenicity and conspicuity of small hepatocellular carcinoma on gray scale sonography after transcatheter arterial chemoembolization.
    Lee MW; Kim YJ; Park SW; Yu NC; Park HS; Jung SI; Jeon HJ
    J Ultrasound Med; 2010 Sep; 29(9):1305-12. PubMed ID: 20733186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Hepatogastroenterology; 2005; 52(65):1344-6. PubMed ID: 16201070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Hashimoto M; Watanabe O; Hirano Y; Kato K; Watarai J
    AJR Am J Roentgenol; 1997 Nov; 169(5):1307-10. PubMed ID: 9353447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
    Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
    AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.
    Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
    Eur Radiol; 2016 Jan; 26(1):225-34. PubMed ID: 25991485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma.
    Chen RC; Liao LY; Wang CS; Chen WT; Wang CK; Li YH; Tu HY; Chen PH
    AJR Am J Roentgenol; 2003 Dec; 181(6):1647-52. PubMed ID: 14627590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
    Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
    J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Vasc Interv Radiol; 2006 Apr; 17(4):723-6. PubMed ID: 16614157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging.
    Youk JH; Lee JM; Kim CS
    J Ultrasound Med; 2003 Sep; 22(9):911-20. PubMed ID: 14510262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous sonographically guided radio frequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session.
    Lee MW; Lim HK; Kim YJ; Choi D; Kim YS; Lee WJ; Cha DI; Park MJ; Rhim H
    J Ultrasound Med; 2011 May; 30(5):607-15. PubMed ID: 21527608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
    Yasumoto T; Hayashi S; Shimizu J; Dono K; Nakata S; Sato M; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2371-3. PubMed ID: 20037426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
    J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced power Doppler sonography and contrast-enhanced harmonic imaging.
    Esteban JM; Gil J
    Acad Radiol; 2002 Aug; 9 Suppl 2():S382-3. PubMed ID: 12188283
    [No Abstract]   [Full Text] [Related]  

  • 19. Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor.
    Ishimaru H; Nakashima K; Sakugawa T; Sakamoto A; Matsuoka Y; Ashizawa K; Uetani M
    AJR Am J Roentgenol; 2014 Apr; 202(4):744-51. PubMed ID: 24660701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.
    Liang HY; Lu LG; Hu BS; Li Y; Shao PJ
    Chin Med J (Engl); 2013 Nov; 126(22):4270-6. PubMed ID: 24238511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.